Bestrophin-2 is a member of the bestrophin family of proteins, which are recognized for their role as calcium-activated chloride channels (CaCCs) situated on the cell membrane. These channels are integral for various physiological functions, as they regulate the passage of chloride ions across the cell membrane in response to intracellular calcium levels. The bestrophin family is comprised of several members, with Bestrophin-1 being the most extensively studied due to its association with certain retinal diseases. Bestrophin-2, while less characterized than its counterpart, is believed to share similar channel properties and functions. Located in various tissues, it plays a role in maintaining the proper ionic balance within cells, ensuring normal cellular function.
Bestrophin-2 inhibitors are compounds designed to modulate the activity of the Bestrophin-2 channel. By interacting with Bestrophin-2, these inhibitors can potentially alter the chloride ion flow across the cell membrane, thereby impacting cellular processes reliant on the precise regulation of ion concentrations. The specific nature and structure of these inhibitors can vary, but they all aim to reduce or block the normal activity of Bestrophin-2 channels. Understanding these inhibitors is crucial for decoding the exact roles of Bestrophin-2 in different cellular contexts. Furthermore, these inhibitors can be invaluable research tools, aiding scientists in investigating the intricate workings of calcium-activated chloride channels and their broader implications in cellular physiology. The exploration and characterization of Bestrophin-2 inhibitors will undoubtedly expand the knowledge base on ion channel regulation and the nuanced roles of the bestrophin family in various physiological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Niflumic acid | 4394-00-7 | sc-204820 | 5 g | $32.00 | 3 | |
Niflumic acid is a nonsteroidal anti-inflammatory drug known to inhibit chloride channels. It might affect BEST2's chloride channel function. | ||||||
Flufenamic acid | 530-78-9 | sc-205699 sc-205699A sc-205699B sc-205699C | 10 g 50 g 100 g 250 g | $27.00 $79.00 $154.00 $309.00 | 1 | |
An NSAID and also known as a chloride channel blocker. Might interfere with BEST2's chloride channel activity. | ||||||
5-Nitro-2-(3-phenylpropylamino)benzoic Acid (NPPB) | 107254-86-4 | sc-201542 sc-201542B sc-201542A | 10 mg 25 mg 50 mg | $109.00 $193.00 $317.00 | 7 | |
A chloride channel blocker that may inhibit BEST2. | ||||||
CFTR Inhibitor-172 | 307510-92-5 | sc-204680 sc-204680A | 10 mg 50 mg | $168.00 $520.00 | 10 | |
Although primarily an inhibitor for CFTR chloride channels, it may have off-target effects on BEST2. | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Known to inhibit various chloride channels; its effect on BEST2 might be explored. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
A calcium channel blocker which might influence BEST2, given its calcium-activated nature. | ||||||
Carbenoxolone disodium | 7421-40-1 | sc-203868 sc-203868A sc-203868B sc-203868C | 1 g 5 g 10 g 25 g | $46.00 $201.00 $358.00 $774.00 | 1 | |
Although primarily a gap junction blocker, it might have off-target effects on chloride channels including BEST2. | ||||||
Glyburide (Glibenclamide) | 10238-21-8 | sc-200982 sc-200982A sc-200982D sc-200982B sc-200982C | 1 g 5 g 25 g 100 g 500 g | $46.00 $61.00 $117.00 $173.00 $530.00 | 36 | |
An ATP-sensitive potassium channel blocker which might have off-target effects on BEST2. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $57.00 $77.00 | 2 | |
An antiparasitic that affects various chloride channels. Its effect on BEST2 is speculative. | ||||||